WWM
SAGE icon

Wolff Wiese Magana’s Sage Therapeutics SAGE Stock Holding History

Wolff Wiese Magana’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$64 – 1025
2025
Q2 		$64 Hold
7
– – ﹤0.01% 963
2025
Q1 		$56 Hold
7
– – ﹤0.01% 976
2024
Q4 		$39 Hold
7
– – ﹤0.01% 950
2024
Q3 		$51 Hold
7
– – ﹤0.01% 979
2024
Q2 		$77 Hold
7
– – ﹤0.01% 770
2024
Q1 		$132 Hold
7
– – ﹤0.01% 692
2023
Q4 		$152 Hold
7
– – ﹤0.01% 686
2023
Q3 		$145 Sell
7
-1,731
-100% -$50K ﹤0.01% 763
2023
Q2 		$81.7K Hold
1,738
– – 0.06% 153
2023
Q1 		$72.9K Hold
1,738
– – 0.06% 153
2022
Q4 		$66.3K Hold
1,738
– – 0.06% 158
2022
Q3 		$68K Hold
1,738
– – 0.05% 198
2022
Q2 		$56K Sell
1,738
-71
-4% -$2.38K 0.04% 235
2022
Q1 		$60K Sell
1,809
-40
-2% -$1.5K 0.04% 242
2021
Q4 		$79K Sell
1,849
-117
-6% -$4.9K 0.05% 226
2021
Q3 		$87K Hold
1,966
– – 0.06% 209
2021
Q2 		$112K Hold
1,966
– – 0.08% 179
2021
Q1 		$147K Buy
1,966
+36
+2% +$2.95K 0.11% 146
2020
Q4 		$167K Buy
+1,930
New +$142K 0.14% 131

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wolff Wiese Magana's SAGE Position: Q3 2025 in Review

Wolff Wiese Magana sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 7 shares — an estimated $64 sold.

Wolff Wiese Magana first reported a position in SAGE in Q4 2020 and held it in 19 quarters. The position peaked at $167K in Q4 2020. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Wolff Wiese Magana reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 7 Sage Therapeutics shares in Q3 2025, an estimated $64.
  • Wolff Wiese Magana first reported a position in Sage Therapeutics in Q4 2020 and held it in 19 quarters.
  • Wolff Wiese Magana's Sage Therapeutics position peaked at $167K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.